Compare RCUS & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | HOG |
|---|---|---|
| Founded | 2015 | 1903 |
| Country | United States | United States |
| Employees | N/A | 6400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2018 | 1994 |
| Metric | RCUS | HOG |
|---|---|---|
| Price | $19.64 | $18.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $28.22 | $27.43 |
| AVG Volume (30 Days) | 913.0K | ★ 3.6M |
| Earning Date | 05-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 3.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.03 |
| Revenue | $247,000,000.00 | ★ $5,186,802,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.47 |
| P/E Ratio | ★ N/A | $3.71 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.79 | $18.65 |
| 52 Week High | $26.40 | $31.25 |
| Indicator | RCUS | HOG |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 32.89 |
| Support Level | $8.86 | N/A |
| Resistance Level | $21.55 | $21.46 |
| Average True Range (ATR) | 1.09 | 0.87 |
| MACD | 0.03 | -0.15 |
| Stochastic Oscillator | 36.70 | 2.30 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.